Ticker brief

RVPH

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
9
authors 14d
3
crowd 14d
+0.35

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-25 · now +0.58 (−1 bearish … +1 bullish)
Who spoke3
authorgradetrader scoresignalsmean sent
@StableBreadA-1.097+0.49
@PrismMarketViewC·1+0.40
@PrismDMA-2.101+0.30
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-25@StableBread+0.60Argues Teva's patent filings do not threaten RVPH and may signal partnership or acquisition interest.·
2026-08-25@StableBread+0.40Reports Zacks's updated $5 DCF value for RVPH versus a $0.46 market price.·
2026-08-25@StableBread+0.75Uses Teva patent precedents and biotech acquisitions to frame major strategic upside for RVPH.·
2026-08-24@StableBread+0.55Teva's long-running patent work on RVPH's drug is framed as evidence of strategic interest.·
2026-08-24@StableBread+0.30Portfolio framework emphasizes downside protection, valuation, sizing and catalysts while discussing disclosed holdings.·
2026-08-23@StableBread+0.25Frames RVPH as below liquidation value while detailing a substantial funding gap and warrant constraints.·
2026-08-20@StableBread+0.55Presents RVPH as deeply undervalued despite delays, citing patent extension and possible TEVA strategic interest.·
2026-08-19@PrismDM+0.30Midday-movers report provides exact gains, losses, prices and volumes.·
2026-08-19@PrismMarketView+0.40Provides intraday prices, percentage moves, ranges, and volumes for multiple stocks.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.